Fulminant hepatic failure (FHF) carries a high mortality. We aimed to review the prognostic factors and explore the potential role of Liver Dialysis (LD).
Fifty-two patients were reviewed. The etiologies were acetaminophen toxicity (33%), viral hepatitis (18%), autoimmune (10%), idiosyncratic drug reactions (8%), others (6%) and undetermined (25%). Patients with acetaminophen had a significantly higher survival compared to the non-acetaminophen group (p=0.04). Patients with grade 3 encephalopathy had a mortality of 68%, among 5 patients with grade IV encephalopathy, 2 survived and both had had treatment with LD.
Chi-square with Fisher's exact test was used for statistical analysis.
Our study confirmed that the diagnosis of non-acetaminophen induced FHF and reduced initial serum factor V level are associated with fatal outcome. Timely OLT significantly improved the survival. The role of LD in hepatic regeneration or as a bridge to OLT needs to be further studied with prospective control trials.
LeeW.M.Acute liver failure. N Engl J Med1993; 329: 1862–72.
2.
BismuthH., SamuelD., CastaingD., WilliamsR., PereiraS.P.Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis1996; 16: 415–25.
3.
RahmanT., HodgsonH.Clinical management of acute hepatic failure. Intensive Care Med2001; 27: 467–76.
4.
HoofnagleJ.H., CarithersR.L., ShapiroC., AscherN.Fulminant hepatic failure: Summary of a workshop. Hepatology1995; 21: 240–52.
O'GradyJ.G., AlexanderGJM, HayllarK.M., WilliamsR.Early indicators of prognosis in fulminant hepatic failure. Gastroenterology1989; 97: 439–45.
17.
TakahashiY., KumadaH., ShimizuM.A multicenter study on the prognosis of fulminant viral hepatitis: Early prediction for liver transplantation. Hepatology1994; 19: 1065–71.
18.
BaileyB., AmreD.K., GaudreaultP.Fulminant hepatic failure secondary to acetaminophen poisoning: A systemic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med2003; 31: 299–305.
19.
AcharyaS.T., PandaS.K., SaxenaA., GuptaS.D.Acute hepatic failure in India. A perspective from the East. J Gastroenterol Hepatol2000; 15: 473–9.
20.
SchiodtF.V., AtillasoyE., ShakilA.O.Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg1999; 5: 86–9.
21.
ShakilA.O., KramerD., MazariegosG.V., FungJ.J., RakelaJ.Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl2000; 6: 163–9.
22.
BowenD.G., ShackelN.A., McCaughanG.W.East meets west: acute liver failure in the global village. J Gastroenterol Hepatol2000; 15: 467–9.
BernalW., WendonJ.Acute liver failure; clinical features and management. Eur J Gastroenterol Hepatol1999; 11: 977–84.
25.
PereiraL.M., LangleyP.G., HayllarK.M., TredgerJ.M., WilliamsR.Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: Relation to other prognostic indicators. Gut1992; 33: 98–102.
26.
LeeW.M., GalbraithR.M., WattG.H.Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology1995; 21: 101–5.
27.
BernuauJ., GoudeauA., PoynardT.Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology1986; 6: 648–51.
DonaldsonB.W., GopinathR., WanlessI.R.The role of transjugular liver biopsy in fulminant liver failure: Relation to other prognostic indicators. Hepatology1993; 18: 1370–4.
30.
HassaneinT.I., WahlstromH.E., ZamoraJ.U., Van ThielD.H.Conventional care of fulminant hepatic failure: Medical and surgical aspects. Ther Apher1997; 1: 33–7.
31.
SingerA.L., OlthoffK.M., KimH., RandE., ZamirG., ShakidA.Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg2001; 234: 418–24.
32.
BernsteinD., TripodiJ.Fulminant hepatic failure. Crit Care Clin1998; 14: 181–97.
33.
RedekerA.G., YamahiroH.S.Controlled trial of exchangetransfusion therapy in fulminant hepatitis. Lancet1973; 1: 3–6.
